Dabur International announces new line of skin care, shampoo, deodorant and hair color that will be launched in 2013
- United Arab Emirates: Monday, January 14 - 2013 at 15:32
- PRESS RELEASE
Dabur International, one of the most trusted and recognized personal and healthcare brands in the world, has announced that it has developed a new line of skin care, shampoo, deodorant and hair color that will be launched in 2013 as part of an intensified growth strategy in the Middle East.
Dabur International also pointed out, "The best-performing product categories in the Middle East market in the past year included Hair Styling, Skin Care, Depilatories and Oral Care. This has led to a growth of up to 20% in sales of Dabur's top-of-the-line products across different key markets in the Middle East in 2012."
"The Middle East market has opened a huge window of opportunity for Dabur International to further expand our product portfolio and widen our global consumer base. The strong demand for our top-of-the-line products in the region has certainly added a tremendous boost to our global expansion plans as we expect to achieve significant business growth in the region in 2013 as well. Our growth strategy will remain firmly focused on broadening our consumer base through geographic expansions, targeting new niche markets and strategic acquisitions. Moreover, focus continues to remain on personal care, including hair care, skin care and oral care, which generated exceptionally strong results in the previous year. Following the successful launch of Vatika Serum, Dabur Herbal Toothpaste, Vatika Henna Hair Colours and Dermoviva Skin Care in the Middle East, we have now lined up a new range of products, including skin care, shampoo, deodorants and hair color as we build on the brand's outstanding performance in 2012," said Mohit Malhotra, CEO, Dabur International.
Having set an extremely high yardstick in its product and process development that continue to meet stringent quality standards, Dabur has been one of the world's most trusted brands in hair care and health care for decades. The company has also diversified into key consumer categories like skin care, oral care, home care and foods through brands like Dabur, Vatika, DermoViva, Fem, Hajmola, Sanifresh and Odonil, which are household names in many parts of the world.
Manufacturing and marketing a diversified product portfolio globally, Dabur has also tailor-made many of its products to fit the diverse needs and preferences of consumers in different regions. New innovations like Hammam Zaith and Snake Oil, for instance, have been especially created for women of the Middle East by Dabur's R&D team comprising over 100 scientists.
Further strengthening the company's global expansion initiative, Dabur has recently made two strategic acquisitions to gain entry into virgin categories and access advanced technologies in the highly developed consumer markets of Turkey and USA. Hobi Kozmetik, a leading personal care company in Turkey was the first overseas acquisition, while Namasté Laboratories, a leader in African American Hair Care based out of Chicago, USA, was the second acquisition.
Dabur International, a wholly owned subsidiary of Dabur India that has an overall turnover of over $1bn and a market capitalization of $4bn. Dabur's International Business Division headquartered in Dubai is the cornerstone of its growth strategy, reaching a milestone of Dhs1bn within only eight years of its existence.
Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com
Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / 4C. AME Info FZ LLC / 4C is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.